Question Bank › The product is disappearing into reorder rhythm

The product is disappearing into reorder rhythm

The product is disappearing into reorder rhythm: revenue is shifting from won-each-time to arriving-on-its-own, and the

Calls Tested
500
Answered YES
5
Hit Rate
1%
rare by design

Treace Medical Concepts, Inc. (TMCI) — this company's answers

NO on the Q2 2022 call 2022-08-13 B+
The model's full reasoning — Q2 2022 call → NOWe need answer YES or NO based on transcript. Need determine if management describes growing share of revenue arrives without new selling event through reorders/refills/renewals/repeat purchases/usage-driven billing/aftermarket/consumable pull-through/customers' own routines, and that this self-arriving share has recently and visibly grown as proportion, grounded in observed current behavior, changing quality of revenue. We need analyze transcript. Company sells Lapiplasty procedure kits, implants, ancillary products. Revenue growth driven by procedure volumes and ASP. Active surgeons base, utilization per surgeon. They mention "surgeon utilization gains" with increasing use of Lapiplasty and Adductoplasty and ancillary products. But is that "self-arriving revenue"? They have direct sales force, DTC, training. Revenue from kits per procedure. Repeat purchases from surgeons? They have active surgeon base, utilization per surgeon increasing. But is that described as self-arriving without selling event? Not exactly. They talk about surgeon utilization increases as surgeons mature, but not necessarily "without new selling event." They have direct sales reps calling on surgeons. DTC drives patients. So revenue still requires selling events? Maybe repeat purchases from existing surgeons are "customers' own standing routines"? But management doesn't frame as self-arriving or proportion growing. They mention "steady gains in active surgeon user base" and "surgeon utilization" up from 9.8 to 10.1 kits per surgeon. But that's not "self-arriving revenue" in sense of reorders/consumables. It's procedure kits sold per surgery; each surgery is a selling event? They have direct reps. No mention of recurring revenue, reorders, consumable pull-through. They do mention "complementary ancillary products" and "displaced competitive forefoot products" but not as self-arriving. They mention "direct sales reps leverage their position in OR and increasingly displace competitive forefoot products with our complementary ancillary products." That's selling.

← Back to the full TMCI analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe that a GROWING SHARE OF THE COMPANY'S REVENUE NOW ARRIVES WITHOUT A NEW SELLING EVENT — through reorders, refills, renewals, repeat purchases, usage-driven billing, aftermarket or consumable pull-through, or customers' own standing routines — AND that this self-arriving share has RECENTLY AND VISIBLY GROWN as a proportion of the business, with management grounding the shift in observed current behavior and treating it as changing the company's quality of revenue? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent recent shift with both halves present: (1) SELF-ARRIVING REVENUE, OBSERVED NOW: management points to real, current repeat-mechanism revenue — reorder rates, renewal behavior, consumable or aftermarket attach, usage growth from installed product, or customers reordering on their own schedule — described with concrete grounding in the recent period, not asserted through generic 'recurring revenue' or 'loyal customers' language; and (2) THE PROPORTION HAS RECENTLY MOVED: management conveys that this self-arriving component is a visibly LARGER share of the business than it recently was — through an installed base that has recently scaled, a consumable or service stream now compounding on top of equipment already placed, or repeat behavior recently strengthening — so the company's revenue is becoming progressively less dependent on winning each sale, with the mix still early in its shift. Answer NO if the business has always been overwhelmingly recurring or contractual with nothing recently shifted. NO if repeat language is boilerplate with no observed behavior or recent change. NO if the repeat revenue is forced by contract lock-in with no customer choice described. NO if the shift is only planned or hoped for. NO if the pattern rests on one anecdote, or appears only in an analyst's question management does not affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
DUOT Duos Technologies Group, Inc. Q4 2023 2024-04-01 F
QTRX Quanterix Corporation Q3 2023 2023-11-07 B
CYBR CyberArk Software Ltd. Q3 2021 2021-11-04 B+
IRBT iRobot Corporation Q3 2021 2021-10-28 D
TOUR Tuniu Corporation Q4 2017 2018-03-14 D

How the model reasoned

DUOT · Q4 2023 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, through reorders, renewals, etc., and that this has recently and visibly grown as a ...
QTRX · Q3 2023 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, like through reorders, consumables, etc., and that this share has recently grown.
CYBR · Q3 2021 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, like through renewals, and that this has recently grown as a proportion.

More from the question bank

Named catch-up gapWorking for customers it could not have servPaid to expand: the company's growth spendinVolume records through a still-fixed gateRecently unlocked doorSelling something whose payoff to the buyer All questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.